|
|
|
|
|
|
|
|
|
|
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
"This study suggests that quantification of the number of EOC stem cells in the tumor can be used as a predictor of disease and could be applied for treatment selection in early-stage ovarian cancer."
"3.6. Correlation between the Number of CD44+ EOC Stem Cells and Progression-Free Survival Although a majority of patients with early-stage ovarian cancer respond to treatment and have a good prognosis, 10% of these patients will recur in spite of appropriate debulking and chemotherapy....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.